Texture Evolution during Recrystallization and Grain Growth in Non-Oriented Electrical Steel Produced by Compact Strip Production Process.

Evolution of texture and α*-fiber texture formation mechanism of Fe-0.65%Si non-oriented electrical steel produced by Compact Strip Production (CSP) process during all the thermo-mechanical processing steps were investigated using electron backscatter diffraction (EBSD) and X-ray diffraction (XRD) techniques. Columnar crystal structure of cast slab is fine and well-developed. Textures of the hot-rolled band are quite different in the thickness direction. During annealing of cold-rolled sheet, γ-fiber texture grains would nucleate and grow preferentially, and α*-fiber texture grains mainly nucleate and grow in the shear zone of α-fiber texture of cold-rolled sheet. During the recrystallization process, γ-fiber texture gradually concentrated to {111}<112>, and γ and α*-fiber texture increased significantly. {111}<112> texture priority nucleation at the initial stage of recrystallization. Due to the advantages of nucleation position and quantity, the content of α*-fiber texture is greater than {111}<112> texture in the mid-recrystallization. During grain growth process, {111}<112> oriented grains would grow selectively by virtue of higher mobility, sizes and quantity advantages than that of {411}<148 > and {100}<120>, resulting in the gradual increase of γ-fiber texture and the decline of α *-fiber texture.

Preliminary biological evaluation of 123I-labelled anti-CD30-LDM in CD30-positive lymphomas murine models.

Overexpression of CD30 has been reported on the surface of some T-cell lymphomas, especially on Hodgkin's lymphoma (HL) and anaplastic large cell lymphoma (ALCL). CD30 targeted immunotherapy has good clinical therapy response. We have produced a novel antibody drug conjugates (ADCs)-anti-CD30-LDM, which shows attractive tumour-targeting capability and extremely potent antitumor efficacy. To further investigate biological characteristics and promote clinical translation of anti-CD30-LDM, we constructed a radiolabeled 123I-anti-CD30-LDM to evaluate the biodistribution characteristics. The anti-CD30-LDM was radioiodinated by the Iodogen method. The radiochemical purity of 123I-anti-CD30-LDM was more over 98%, and the specific activity of 240.5 MBq/mg. The stability and the specificity of 123I-anti-CD30-LDM were evaluated in vitro. Cellular binding assays were used to evaluate the binding capabilities in CD30-positive Karpas299 cells and CD30-negative Raji cells. B-NDG mice bearing Karpas 299 and Raji xenografts were used for in vivo biodistribution studies. Our results demonstrated that anti-CD30-LDM as an ideal ADC targeted to CD30, which was labelled easily with 123I and obtained the sufficient yields. The 123I-anti-CD30-LDM preserved specific binding to CD30 in vitro and uptake in tumour xenografts in B-NDG mice. These results are encouraging for anti-CD30-LDM as a promising clinical translational candidate for various CD30 positive lymphomas and other diseases.

Elevated expression of the V-ATPase D2 subunit triggers increased energy metabolite levels in KrasG12D -driven cancer cells.

Mutations of the Ras oncogene are frequently detected in human cancers. Among Ras-mediated tumorigenesis, Kras-driven cancers are the most dominant mutation types. Here, we investigated molecular markers related to the Kras mutation, which is involved in energy metabolism in Kras mutant-driven cancer. We first generated a knock-in KrasG12D cell line as a model. The genotype and phenotype of the Kras G12D -driven cells were first confirmed. Dramatically elevated metabolite characterization was observed in Kras G12D -driven cells compared with wild-type cells. Analysis of mitochondrial metabolite-related genes showed that two of the 84 genes in Kras G12D -driven cells differed from control cells by at least twofold. The messenger RNA and protein levels of ATP6V0D2 were significantly upregulated in Kras G12D -driven cells. Knockdown of ATP6V0D2 expression inhibited motility and invasion but did not affect the proliferation of Kras G12D -driven cells. We further investigated ATP6V0D2 expression in tumor tissue microarrays. ATP6V0D2 overexpression was observed in most carcinoma tissues, such as melanoma, pancreas, and kidney. Thus, we suggest that ATP6V0D2, as one of the V-ATPase (vacuolar-type H + -ATPase) subunit isoforms, may be a potential therapeutic target for Kras mutation cancer.

Suppression of Dendritic Lithium Growth by in Situ Formation of a Chemically Stable and Mechanically Strong Solid Electrolyte Interphase.

The growth and proliferation of Li dendrites during repeated Li cycling has long been a crucial issue that hinders the development of secondary Li-metal batteries. Building a stable and robust solid state electrolyte interphase (SEI) on the Li-anode surface is regarded as a promising strategy to overcome the dendrite issues. In this work, we report a simple strategy to engineer the interface chemistry of Li-metal anodes by using tiny amounts of dimethyl sulfate (DMS, C2H6SO4) as the SEI-forming additive. With the preferential reduction of DMS, an SEI layer composed of Li2S/Li2O forms on the Li surface. This inorganic SEI layer features high structural modulus and low interfacial resistant, enabling a dense and dendrite-free Li deposition as evidenced by scanning electron microscopy, atomic force microscopy, and in situ optical images. In addition, this SEI layer can prevent the deposited Li from direct contact with corrosive electrolytes, thus rendering an improved cycling stability of Li anodes with an average Coulombic efficiency of 97% for up to 150 cycles. When the DMS additive is introduced into a Li/NCM full cell, the cycle life of Li-metal batteries can be also improved significantly. This work demonstrates a feasible route to suppress Li dendrite growth by designing appropriate film-forming additives to regulate the interfacial properties of the SEI layer, and also the sulfonyl-based derivatives revealed in this work represent a large variety of new film-forming molecules, providing a broad selectivity for constructing high efficiency and cycle-stable Li anodes to address the intrinsic problems of rechargeable Li-metal batteries.

Th(IV) adsorption on alumina: effects of contact time, pH, ionic strength and phosphate.

Adsorption of Th(IV) (total concentration, 10(-5)-10(-4) mol/L) was studied by a batch technique. The effects of pH, ionic strength, contact time, and phosphate on the adsorption of Th(IV) onto alumina were investigated. Adsorption isotherms of Th(IV) on alumina at approximately constant pH and three ionic strengths (0.05, 0.1, 0.5 mol/L KNO3) were determined. It was found that the pH values of aqueous solutions of both the Th(IV)-alumina and phosphate-alumina adsorption systems increase with increasing contact time, respectively. Adsorption of Th(IV) on alumina steeply increases with increasing pH from 1 to 4.5 and the adsorption edge consists of three regions. The phosphate added clearly enhances Th(IV) adsorption in the pH range 1-4. From the adsorption isotherms at approximately constant pH and three different ionic strengths, a reduced ionic strength effect was observed and is contradictory to the insensitive effect obtained from the adsorption edges on three oxides of Fe, Al, and Si at different ionic strengths. Compared with the adsorption edges at different ionic strengths, the adsorption isotherms at approximately constant pH and different ionic strengths are more advantageous in the investigation of ionic strength effect. The significantly positive effect of phosphate on Th(IV) adsorption onto alumina was attributed to strong surface binding of phosphate on alumina and the subsequent formation of ternary surface complexes involving Th(IV) and phosphate.